Wang, Xia, Minhas, Jatinder S., Broderick, Joseph P., Demchuk, Andrew M., Donnan, Geoffrey A., Durham, Alice C., Lavados, Pablo M., Lee, Tsong-Hai, Levi, Christopher, Martins, Sheila O., Olavarria, Veronica V., Pandian, Jeyaraj D., Moullaali, Tom J., Parsons, MW, Pontes-Neto, OM, Ricci, S, Sato, S, Sharma, VK, Silva, F, Thang, NH, Wang, J-G, Woodward, M, Chalmers, J, Di Tanna, Gian Luca, Song, L, Anderson, CS, Robinson, TG, ENCHANTED Investigators,, Lindley, Richard I., Chen, Xiaoying, Arima, Hisatomi, Chen, Guofang, Delcourt, Candice, Bath, Philip M.. Lippincott Williams & Wilkins; 2022. Associations of Early Systolic Blood Pressure Control and Outcome after Thrombolysis-Eligible Acute Ischemic Stroke: Results from the ENCHANTED Study.

Coutts, Shelagh B., Ankolekar, Sandeep, Camden, Marie-Christine, Campbell, Bruce C. V., Casaubon, Leanne K., Catanese, Luciana, Chatterjee, Kausik, Choi, Philip M. C., Clarke, Brian, Dowlatshahi, Dar, Ferrari, Julia, Field, Thalia S., Appireddy, Ramana, Ganesh, Aravind, Ghia, D, Goyal, M, Greisenegger, S, Halse, O, Horn, M, Hunter, G, Imoukhuede, O, Kelly, PJ, Kennedy, J, Arenillas, Juan F., Kenney, C, Kleinig, TJ, Krishnan, K, Lima, F, Mandzia, JL, Marko, M, Martins, SO, Medvedev, G, Menon, BK, Mishra, SM, Assis, Zarina, Molina, C, Moussaddy, A, Muir, KW, Parsons, MW, Penn, AMW, Pille, A, Pontes-Neto, OM, Roffe, C, Serena, J, Simister, R, Bailey, Peter, Singh, N, Spratt, Neil, Strbian, D, Tham, CH, Wiggam, MI, Williams, DJ, Willmot, MR, Wu, T, Yu, AYX, Zachariah, G, Barber, Philip A., Zafar, A, Zerna, C, Hill, MD, Salluzzi, M, Blenkin, N, Dueck, A, Doram, C, Zhang, Q, Ryckborst, K, Bohn, S, Bazan, Rodrigo, Collier, Q, Taylor, F, Lethebe, BC, Jambula, A, Sage, K, Toussaint, L, Save, S, Lee, J, Laham, N, Sultan, AA, Buck, Brian H., Deepak, A, Sitaram, A, Demchuk, AM, Lockey, A, Micielli, A, Wadhwa, A, Arabambi, B, Graham, B, Bogiatzi, C, Doshi, D, Butcher, Ken S., Chakraborty, D, Kim, D, Vasquez, D, Singh, D, Tse, D, Harrison, E, Smith, EE, Teleg, E, Klourfeld, E, Klein, G. The Lancet Publishing Group; 2024. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.